Philip E. Lammers

Hematology Oncology | Hematology | Oncology

2996 Kate Bond Rd Ste 100
Bartlett, TN 38133

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Patient-reported outcomes with tarlatamab in extensive-stage small cell lung cancer after platinum-based chemotherapy: results from the phase 3 DeLLphi-304 trial.

Patient-reported outcomes with tarlatamab in extensive-stage small cell lung cancer after platinum-based chemotherapy: results from the phase 3 DeLLphi-304 trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 08, 2026

Barriers to Lung Cancer Screening in a Multi-Disciplinary Thoracic Oncology Program Cohort: Effects of an Incidental Pulmonary Nodule Program.

Barriers to Lung Cancer Screening in a Multi-Disciplinary Thoracic Oncology Program Cohort: Effects of an Incidental Pulmonary Nodule Program.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: October 07, 2024

Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.

Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.

Journal: Cancer

Published: September 30, 2024

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors.

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors.

Journal: JTO clinical and research reports

Published: September 22, 2023

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.

Journal: medRxiv : the preprint server for health sciences

Published: May 19, 2023

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.

Journal: eLife

Published: August 11, 2022

The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network.

The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: January 05, 2022

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials.

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials.

Journal: Cancer medicine

Published: March 01, 2021

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 30, 2020

Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Health Care System.

Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Health Care System.

Journal: JTO clinical and research reports

Published: December 21, 2020

Increased ease of access to genetic counseling for low-income women with breast cancer using a point of care screening tool.

Increased ease of access to genetic counseling for low-income women with breast cancer using a point of care screening tool.

Journal: Journal of community genetics

Published: May 30, 2020

Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network.

Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network.

Journal: Journal of personalized medicine

Published: March 30, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026